CD8A and neoplasm: The predictive values of tumor programmed death ligand-1 (PD-L1) expression 23, CD8+ tumor-infiltrating lymphocytes (TILs) 23, and high tumor mutational burden (TMB) 24 density have been demonstrated to be associated with ICIs efficacy, however, the immune composition and expression of potentially actionable immunostimulatory targets in SCLC are poorly understood.